1 – 50 of 121
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Impact of Magnetic Resonance Imaging Markers on the Diagnostic Performance of the International Parkinson and Movement Disorder Society Multiple System Atrophy Criteria
2024) In Movement Disorders(
- Contribution to journal › Article
-
Mark
Care of Late-Stage Parkinsonism : Resource Utilization of the Disease in Five European Countries
(
- Contribution to journal › Article
- 2023
-
Mark
Dopamine Agonist Cotreatment Alters Neuroplasticity and Pharmacology of Levodopa-Induced Dyskinesia
(
- Contribution to journal › Article
-
Mark
Investigation of Shared Genetic Risk Factors Between Parkinson's Disease and Cancers
(
- Contribution to journal › Article
-
Mark
Embracing Monogenic Parkinson's Disease : The MJFF Global Genetic PD Cohort
(
- Contribution to journal › Article
-
Mark
Does fatigue in Parkinson’s disease impact one’s physical function in daily live?
2023) The 2023 Inational Congress of Parkinson’s Disease and Movement Disorderst(
In Movement Disorders 38(Suppl 1). p.824-824- Contribution to journal › Published meeting abstract
-
Mark
Levodopa Dose Equivalency in Parkinson's Disease : Updated Systematic Review and Proposals
(
- Contribution to journal › Article
-
Mark
Cerebrospinal Fluid Biomarkers of Synaptic Dysfunction Are Altered in Parkinson's Disease and Related Disorders
(
- Contribution to journal › Article
-
Mark
Reply to Letter to the Editor : “Disease Progression in Multiple System Atrophy: The Value of Clinical Cohorts with Long Follow-Up”
(
- Contribution to journal › Letter
-
Mark
A Screening Tool to Quickly Identify Movement Disorders in Patients with Inborn Errors of Metabolism
(
- Contribution to journal › Article
- 2022
-
Mark
Disease Progression in Multiple System Atrophy—Novel Modeling Framework and Predictive Factors
(
- Contribution to journal › Article
-
Mark
The Interaction between HLA-DRB1 and Smoking in Parkinson's Disease Revisited
(
- Contribution to journal › Article
-
Mark
Dairy Intake and Parkinson's Disease : A Mendelian Randomization Study
(
- Contribution to journal › Article
-
Mark
The Neuroinflammatory Acute Phase Response in Parkinsonian-Related Disorders
(
- Contribution to journal › Article
- 2021
-
Mark
A Modified Progressive Supranuclear Palsy Rating Scale
(
- Contribution to journal › Article
-
Mark
Comparison of Locus Coeruleus Pathology with Nigral and Forebrain Pathology in Parkinson's Disease
(
- Contribution to journal › Article
-
Mark
From iPS Cells to Rodents and Nonhuman Primates : Filling Gaps in Modeling Parkinson's Disease
(
- Contribution to journal › Article
-
Mark
Plasma Phospho-Tau Identifies Alzheimer's Co-Pathology in Patients with Lewy Body Disease
(
- Contribution to journal › Article
-
Mark
Replication of a Novel Parkinson's Locus in a European Ancestry Population
(
- Contribution to journal › Article
-
Mark
Genotype–Phenotype Relations for the Atypical Parkinsonism Genes : MDSGene Systematic Review
(
- Contribution to journal › Scientific review
-
Mark
Parkinson's Disease and Post–COVID-19 Syndrome : The Parkinson's Long-COVID Spectrum
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Can reduced attention or visuoexecutive functioning predict perceived walking difficulties in people with Parkinson’s disease (PD)?
(
- Contribution to journal › Published meeting abstract
- 2020
-
Mark
Alcohol Consumption and Risk of Parkinson's Disease : Data from a Large Prospective European Cohort
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid levels of neurogranin in Parkinsonian disorders
(
- Contribution to journal › Article
-
Mark
Dyskinesia matters
(
- Contribution to journal › Article
-
Mark
A Phase 2a Trial Investigating the Safety and Tolerability of the Novel Cortical Enhancer IRL752 in Parkinson's Disease Dementia
(
- Contribution to journal › Article
-
Mark
Validation of the movement disorder society criteria for the diagnosis of 4-repeat tauopathies
(
- Contribution to journal › Article
-
Mark
Reply to : Letter to Editor by Chaudhuri, Jenner, Antonini
(
- Contribution to journal › Letter
-
Mark
The Parkinson's Disease Genome-Wide Association Study Locus Browser
2020) In Movement Disorders(
- Contribution to journal › Article
-
Mark
Clinical Conditions “Suggestive of Progressive Supranuclear Palsy”—Diagnostic Performance
(
- Contribution to journal › Article
- 2019
-
Mark
EuroInf 2 : Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease
2019) In Movement Disorders(
- Contribution to journal › Article
-
Mark
Variable Interpretation of the Dystonia Consensus Classification Items Compromises Its Solidity
(
- Contribution to journal › Article
-
Mark
Nomenclature of Genetically Determined Myoclonus Syndromes : Recommendations of the International Parkinson and Movement Disorder Society Task Force
(
- Contribution to journal › Scientific review
-
Mark
Seeding of protein aggregation causes cognitive impairment in rat model of cortical synucleinopathy
(
- Contribution to journal › Article
- 2018
-
Mark
11C-PE2I and 18F-Dopa PET for assessing progression rate in Parkinson's : A longitudinal study
(
- Contribution to journal › Article
-
Mark
Animal models of l-dopa-induced dyskinesia in Parkinson's disease
(
- Contribution to journal › Scientific review
-
Mark
Eye movement disorders and neurological symptoms in late-onset inborn errors of metabolism
(
- Contribution to journal › Scientific review
-
Mark
Progressive myoclonus ataxia : Time for a new definition?
(
- Contribution to journal › Article
-
Mark
Treatable inherited rare movement disorders
(
- Contribution to journal › Scientific review
- 2017
-
Mark
Increased basal ganglia binding of 18F-AV-1451 in patients with progressive supranuclear palsy
(
- Contribution to journal › Article
-
Mark
PBB3 imaging in Parkinsonian disorders : Evidence for binding to tau and other proteins
(
- Contribution to journal › Article
-
Mark
Factors associated with perceived walking difficulties in people with Parkinson’s disease
(
- Contribution to journal › Published meeting abstract
-
Mark
Clinical diagnosis of progressive supranuclear palsy : The movement disorder society criteria
(
- Contribution to journal › Article
-
Mark
Which ante mortem clinical features predict progressive supranuclear palsy pathology?
(
- Contribution to journal › Scientific review
-
Mark
Dystonia-deafness syndrome caused by a β-actin gene mutation and response to deep brain stimulation
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
A post hoc study on gene panel analysis for the diagnosis of dystonia
(
- Contribution to journal › Article
- 2016
-
Mark
Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's Disease.
2016) In Movement Disorders(
- Contribution to journal › Article
-
Mark
Integrated Safety of Levodopa-Carbidopa Intestinal Gel From Prospective Clinical Trials.
(
- Contribution to journal › Article
-
Mark
On the Effect of Eltoprazine in Dyskinetic Hemiparkinsonian Rats.
(
- Contribution to journal › Letter
-
Mark
Longitudinal changes in CSF alpha-synuclein species reflect Parkinson's disease progression
(
- Contribution to journal › Article